Acticor Biotech SA
PAR:ALACT
Income Statement
Earnings Waterfall
Acticor Biotech SA
Revenue
|
0
EUR
|
Operating Expenses
|
-16.7m
EUR
|
Operating Income
|
-16.7m
EUR
|
Other Expenses
|
-2m
EUR
|
Net Income
|
-18.6m
EUR
|
Income Statement
Acticor Biotech SA
Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||
Revenue |
18
N/A
|
18
+0%
|
20
+12%
|
20
+1%
|
17
-15%
|
16
-7%
|
14
-13%
|
11
-20%
|
9
-20%
|
7
-21%
|
4
-42%
|
3
-34%
|
0
N/A
|
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | |||||||||||||||||||||
Cost of Revenue |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
18
N/A
|
18
+0%
|
19
+11%
|
20
+1%
|
17
-12%
|
16
-7%
|
14
-14%
|
11
-21%
|
9
-22%
|
7
-22%
|
4
-41%
|
3
-33%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||||
Operating Expenses |
(15)
|
(16)
|
(17)
|
(19)
|
(19)
|
(17)
|
(14)
|
(12)
|
(10)
|
(8)
|
(5)
|
(4)
|
(5)
|
(4)
|
(8)
|
(10)
|
(12)
|
(13)
|
(15)
|
(17)
|
|
Selling, General & Administrative |
(14)
|
(15)
|
(17)
|
(18)
|
(18)
|
(16)
|
(13)
|
(11)
|
(10)
|
(7)
|
(5)
|
(4)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(4)
|
(3)
|
(3)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(3)
|
(7)
|
(10)
|
(11)
|
(11)
|
(14)
|
(15)
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
0
|
1
|
2
|
3
|
2
|
2
|
2
|
|
Operating Income |
3
N/A
|
2
-31%
|
2
+20%
|
1
-67%
|
(2)
N/A
|
(1)
+52%
|
(0)
+87%
|
(1)
-952%
|
(2)
-79%
|
(1)
+41%
|
(1)
-20%
|
(2)
-15%
|
(5)
-240%
|
(4)
+32%
|
(8)
-114%
|
(10)
-31%
|
(12)
-20%
|
(13)
-13%
|
(15)
-13%
|
(17)
-10%
|
|
Pre-Tax Income | |||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(3)
|
(3)
|
(0)
|
(1)
|
(0)
|
(7)
|
(8)
|
(1)
|
(4)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
|
Pre-Tax Income |
2
N/A
|
2
-37%
|
(1)
N/A
|
(3)
-166%
|
(2)
+17%
|
(1)
+34%
|
(1)
+63%
|
(8)
-1 459%
|
(10)
-22%
|
(2)
+78%
|
(6)
-159%
|
(8)
-49%
|
(5)
+38%
|
(4)
+30%
|
(8)
-108%
|
(10)
-32%
|
(13)
-24%
|
(14)
-11%
|
(16)
-13%
|
(19)
-17%
|
|
Net Income | |||||||||||||||||||||
Tax Provision |
(1)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
2
|
1
|
(1)
|
(2)
|
(1)
|
(1)
|
(0)
|
(8)
|
(10)
|
(3)
|
(6)
|
(9)
|
(5)
|
(4)
|
(8)
|
(10)
|
(13)
|
(14)
|
(16)
|
(19)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
2
N/A
|
1
-37%
|
(1)
N/A
|
(2)
-107%
|
(1)
+32%
|
(1)
+35%
|
(0)
+46%
|
(8)
-1 646%
|
(10)
-25%
|
(3)
+74%
|
(6)
-115%
|
(9)
-54%
|
(5)
+44%
|
(4)
+27%
|
(8)
-108%
|
(10)
-32%
|
(13)
-24%
|
(14)
-11%
|
(16)
-13%
|
(19)
-17%
|
|
EPS (Diluted) |
0.5
N/A
|
0.31
-38%
|
-0.29
N/A
|
-0.6
-107%
|
-0.41
+32%
|
-0.26
+37%
|
-0.14
+46%
|
-2.49
-1 679%
|
-3.13
-26%
|
-0.82
+74%
|
-1.75
-113%
|
-2.71
-55%
|
-0.48
+82%
|
-0.34
+29%
|
-0.73
-115%
|
-0.96
-32%
|
-1.62
-69%
|
-1.32
+19%
|
-1.51
-14%
|
-1.6
-6%
|